Important information for our community: | |||
COVID-19 Resource Center | Your Care During the Pandemic |
List of Clinical Studies |
|
Cardiology | |
Study Name | Principal Investigator |
![]() |
|
Aegis II– A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group
study to investigate the efficacy and safety of CSL112 in subjects with acute coronary syndrome. Read more. |
Angel Mulkay, MD |
![]() |
|
Esperion 1002-043– A randomized, double-blind, placebo-controlled study to access the effects
of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular events in patients
with, or at high risk for, cardiovascular disease who are statin intolerant. Read more. |
Angel Mulkay, MD |
![]() |
|
CONNECT-HF– Care optimization through patient and hospital engagement clinical trial for
heart failure. Read more. |
Angel Mulkay, MD |
![]() |
|
SAFE-STEMI– Study of access for enhancing percutaneous coronary intervention (PCI) in ST-
elevation myocardial infarction (STEMI) for seniors. Read more. |
Angel Mulkay, MD |
![]() |
|
UPSTREAM– Utilization of Ticagrelor in the upstream setting for non-ST-segment elevation
acute coronary syndrom : an ED-based clinical registry. Read more. |
Angel Mulkay, MD |
![]() |
|
SELECT-4388– Semaglutide effects on heart disease and stroke in people with overweight or
obesity. Read more. |
Thomas Birch, MD |
![]() |
|